MedTrace Logo

A Randomized Controlled Trial of a Bone Density Decision Aide

NCT00285168 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2012-07-20

No results posted yet for this study

Summary

This research study is being conducted to determine if a modified bone mineral density (BMD) test report that contains additional fracture risk information will be a useful physician decision aide in selecting patients for pharmacological osteoporosis therapy. It is hypothesized that this supplementary information, provided in addition to the conventional BMD report, will increase the likelihood that patients at high risk for an osteoporotic fracture will receive prescribed therapy for osteoporosis.

Conditions

Interventions

BEHAVIORAL

Bone Density Decision Aide

Absolute 10-year Fracture Risk Report

Sponsors & Collaborators

  • University of Manitoba

    lead OTHER

Principal Investigators

  • William D Leslie, MD FRCPC · University of Manitoba

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-05-31
Primary Completion
2008-03-31
Completion
2010-03-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00285168 on ClinicalTrials.gov